IBC is providing business advisory services to CERIA Beverages assisting with brand creation, strategy, business establishment and industry guidance. Online PR News � 24-May-2018 � InterContinental Beverage Capital, Inc. (IBC) IBC is a New York-based merchant banking and advisory firm with representative offices in Atlanta, Boca Raton, and Lugano, Switzerland. IBC is helping emerging brands navigate the complex US and Global beverage landscape. CERIA beverages A NEW FUNCTIONAL FRONTIER According to Keith Villa, Co-Founder, and Brewmaster of CERIATM Beverages, CERIA will be brewed just like an alcoholic craft beer to maintain its great beer taste and aroma but will then be de-alcoholized prior to the infusion of a special cannabis formula by a licensed processor. ebbusTM leading pharmacology team has spent over 4 years studying and developing various cannabis sensations for end users. Through this effort, they have developed consistent formulations that will deliver reliable, repeatable and predictable cannabis experiences such as chill, bliss, and energy to consumers. These cannabis formulations containing THC, CBD and other cannabinoids and terpenes will be processed and infused by licensed marijuana processors, bottled and/or canned on-site by the licensee, and then sold chilled in licensed dispensaries in the state of distribution, first in Colorado, then in other states where the use of recreational marijuana is legal. John Carson, IBCs Chairman indicated, by IBC contributing to the safe and informed development of this industry through CERIATM, it helps us deliver on our increasing focus on being involved with platform opportunities across the beverage industry. Stephen Horgan, Co-Founding Partner of IBC, formerly with The Coca-Cola Company and MolsonCoors, offered, We at IBC weighed all options before making the decision to join in helping to build this portion of the industry though CERIATM. After those discussions, we agreed this would be a significant contributor to future functionality for beverages. It opens an entirely new frontier for the industry, both in THC and CBD enhanced beverages that are clinically supported with specific targeted usage purposes. Ultimately, with our deep industry experience and influence, we felt we could help shape this in a positive way by being involved versus watching from the sidelines. And with partners like Keith and Jodi at CERIATM along with ebbuTM it made the decision even clearer. We feel CERIATM will be the first true crossover consumer product infused with THC. And as such, it will help create the model and pave the way for other consumer accepted beverages and consumables. "We have always loved what Keith stands for great-tasting mainstream beers that really kick-started the entire craft beer movement," said Jon Cooper, ebbu'sTM CEO. "We are honored and thrilled to partner with Keith, Jodi, CERIA and IBC to bring this groundbreaking new product to cannabis consumers in legalized states." CERIATM and IBCs objective is to have the first CERIATM cannabis infused non-alcohol craft beer on the dispensary shelves in at least one of the legalized states by the end of 2018. About InterContinental Beverage Capital, Inc. IBC is a New York-based merchant bank and advisory firm focused on the beverage and consumer packaged goods industries. IBC has a worldwide network of strategic industry relationships, lending institutions, consultants, recruiters, and management team resources that provide expertise, advanced industry capabilities, access to new customers, and valuable investment and commercial banking capabilities to potential clients and partnership companies. IBC is actively seeking investments in its targeted verticals, in companies that have unique products and dedicated management that exhibit the ability to develop into category leaders. For more information log onto www.inbevcapital.com Company Contacts: InterContinental Beverage Capital, Investor Relations, 212-634-7277, [email protected] CERIATM Beverages is located in Arvada, Colorado. For more information: ceriabeverages.com Colorado-based ebbuTM is generating clinically-proven cannabinoid formulations for medicine, and mainstreaming adult-use cannabis by creating consistent, predictable sensations. ebbu partners with category-leading companies to power infused products using its patented, lab-tested and science-based platform. For more information: ebbu.com |
Investor Relations |
http://www.inbevcapital.com |
2126347277 |